Section: Endocrine Sub-section: Parathyroid
Overview
- Very rare
- Can present with extreme hypercalcaemia, severe bone disease, or renal stones.
- Other symptoms include weakness, extreme tiredness, confusion, nausea and vomiting, weight loss, polyuria
- 50% of patients will present with a palpable neck mass (which never occurs with an adenoma).
Causes
- Association Hyperparathyroidism-Jaw Tumour syndrome
- Germline CDC73 mutations
- Encode a protein parafibromin which is a tumour suppressor gene - many sporadic cancers also exhibit mutations in this gene.
- Parafibromin is stained for on histology - as malignant tumours generally have loss of parafibromin.
- Germline CDC73 mutations
Pathology
- Appear as greyish-white, and adherent to adjacent structures, like the thyroid, trachea, and neck muscles.
- Histology
- Bizarre nuclear atypia
- Mitotic figures
- Capsular invasion
- Only definitive criteria for malignancy
- Local invasion
- Metastatic disease
- Lung, liver, LNs
Treatment
- Must be prepared to do oncologic resection if required on exploration
- Classically find adherence to surrounding structures or invasion intra-operatively, with dense scarring
- If suspected pre-op
- “At risk group”
- Severe hypercalcaemia, very high PTH, and palpable tumour
- Perform En-bloc resection of parathyroid tumour, ipsilateral thyroid lobe, ipsilateral parathyroid, and adjacent nodes
- May have to sacrifice RLN if invaded
- Routinely explore contralateral parathyroids
- If diagnosis made post-op after parathyroidectomy
- Re-operate and remove ipsilateral thyroid and parathyroid, and LNs